$0.0112
-0.0055[-32.93%]
At close: May 15
$0.0112
0[0.00%]
After Hours: 7:10PM EDT
TC BioPharm (Holdings)
(NASDAQ:TCBPW)Latest News for TC BioPharm (Holdings) Stock (NASDAQ:TCBPW)
TC BioPharm (Holdings) Stock (NASDAQ: TCBPW)
Categories: All
Tuesday, February 21, 2023
- TC BioPharm Shares Halted On Circuit Breaker; Stock Trading Lower During The Company's Shareholder Update Conference CallHappy Mohamed - Feb 21, 2023, 12:37PM
- TC BioPharm Announces Publication Of Paper In AML Research Highlighting The Company's Development Of Allogeneic Gamma-Delta T Cell TherapiesHappy Mohamed - Feb 21, 2023, 8:43AM
Tuesday, February 14, 2023
Thursday, January 19, 2023
Tuesday, January 17, 2023
Monday, November 28, 2022
Tuesday, November 22, 2022
- TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid LeukemiaKenneth Adams - Sponsored
- TC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating Its Lead Compound, OmnImmune, In Patients With Acute Myeloid LeukemiaBenzinga Newsdesk - Nov 22, 2022, 8:12AM